A-kinase anchoring proteins interact with phosphodiesterases in T lymphocyte cell lines

Journal of Immunology

Volumn 173, Issue 8, 2004, Pages 4806-4814

  Asirvatham, Angela L ^a,c   Galligan, Sarah G ^a   Schillace, Robynn V ^a   Davey, Michael P ^a   Vasta, Valeria ^b   Beavo, Joseph A ^b   Carr, Daniel W ^a,d  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c University of New York   (United States)

^d PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN; IMMUNOGLOBULIN G; PHOSPHODIESTERASE; PROTEIN SUBUNIT;

ARTICLE; BONE MARROW CELL; CELL ACTIVATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME ACTIVITY; GENE TRANSLOCATION; GOLGI COMPLEX; GOLGI STAIN; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; LEUKEMIA CELL LINE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN HYDROLYSIS; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; T LYMPHOCYTE;

EID: 6344221448     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.8.4806     Document Type: Article

References (37)

1. Kammer, G. M. 1988. The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response. Immunol. Today 9:222.
2. Torgersen, K. M., T. Vang, H. Abrahamsen, S. Yaqub, and K. Tasken. 2002. Molecular mechanisms for protein kinase A-mediated modulation of immune function. Cell. Signal. 14:1.
3. Michel, J. J., and J. D. Scott. 2002. AKAP mediated signal transduction. Annu. Rev. Pharmacol. Toxicol. 42:235.
4. Alto, N., J. J. Carlisle Michel, K. L. Dodge, L. K. Langeberg, and J. D. Scott. 2002. Intracellular targeting of protein kinases and phosphatases. Diabetes 51(Suppl. 3):S385.
5. Schillace, R. V., S. F. Andrews, G. A. Liberty, M. P. Davey, and D. W. Carr. 2002. Identification and characterization of myeloid translocation gene 16b as a novel a kinase anchoring protein in T lymphocytes. J. Immunol. 168:1590.
6. Dodge, K. L., S. Khouangsathiene, M. S. Kapiloff, R. Mouton, E. V. Hill, M. D. Houslay, L. K. Langeberg, and J. D. Scott. 2001. mAKAP assembles a protein kinase A/PDE4 phosphodiesterase cAMP signaling module. EMBO J. 20:1921.
7. Tasken, K. A., P. Collas, W. A. Kemmner, O. Witczak, M. Conti, and K. Tasken. 2001. Phosphodiesterase 4D and protein kinase a type II constitute a signaling unit in the centrosomal area. J. Biol. Chem. 276:21999.
8. Essayan, D. M. 2001. Cyclic nucleotide phosphodiesterases. J. Allergy Clin. Immunol. 108:671.
9. Li, L., C. Yee, and J. A. Beavo. 1999. CD3- and CD28-dependent induction of PDE7 required for T cell activation. Science 283:848.
10. Houslay, M. D., and G. Milligan. 1997. Tailoring cAMP-signalling responses through isoform multiplicity. Trends Biochem. Sci. 22:217.
11. Conti, M., and S. L. Jin. 1999. The molecular biology of cyclic nucleotide phosphodiesterases. Prog. Nucleic Acid Res. Mol. Biol. 63:1.
12. Manganiello, V. C., and E. Degerman. 1999. Cyclic nucleotide phosphodiesterases (PDEs): diverse regulators of cyclic nucleotide signals and inviting molecular targets for novel therapeutic agents. Thromb. Haemostasis 82:407.
13. Soderling, S. H., and J. A. Beavo. 2000. Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functions. Curr. Opin. Cell. Biol. 12:174.
14. Francischi, J. N., C. M. Yokoro, S. Poole, W. L. Tafuri, F. Q. Cunha, and M. M. Teixeira. 2000. Anti-inflammatory and analgesic effects of the phosphodiesterase 4 inhibitor rolipram in a rat model of arthritis. Eur. J. Pharmacol. 399:243.
15. Souness, J. E., D. Aldous, and C. Sargent. 2000. Immunosuppressive and antiinflammatory effects of cyclic AMP phosphodiesterase (PDE) type 4 inhibitors. Immunopharmacology 47:127.
16. + memory T cells by HIV-1 requires expression of phosphodiesterase 4. J. Immunol. 165:1755.
17. + T-lymphocytes: role in regulating proliferation and the biosynthesis of interleukin-2. Br. J. Pharmacol. 118:1945.
18. Jimenez, J. L., C. Punzon, J. Navarro, M. A. Munoz-Fernandez, and M. Fresno. 2001. Phosphodiesterase 4 inhibitors prevent cytokine secretion by T lymphocytes by inhibiting nuclear factor-κB and nuclear factor of activated T cells activation. J. Pharmacol. Exp. Ther. 299:753.
19. Kaminuma, O., A. Mori, K. Wada, H. Kikkawa, K. Ikezawa, M. Suko, and H. Okudaira. 1998. A selective type 4 phosphodiesterase inhibitor, T-440, modulates intracellular cyclic AMP level and interleukin-2 production of Jurkat cells. Immunopharmacology 38:247.
20. Ekholm, D., J. C. Mulloy, G. Gao, E. Degerman, G. Franchini, and V. C. Manganiello. 1999. Cyclic nucleotide phosphodiesterases (PDE) 3 and 4 in normal, malignant, and HTLV-I transformed human lymphocytes. Biochem. Pharmacol 58:935.
21. Vig, M., A. George, R. Sen, J. Durdik, S. Rath, and V. Bal. 2002. Commitment of activated T cells to secondary responsiveness is enhanced by signals mediated by cAMP-dependent protein kinase A-I. Mol. Pharmacol. 62:1471.
22. Glavas, N. A., C. Ostenson, J. B. Schaefer, V. Vasta, and J. A. Beavo. 2001. T cell activation up-regulates cyclic nucleotide phosphodiesterases 8A1 and 7A3. Proc. Natl. Acad. Sci. USA 98:6319.
23. Houslay, M. D., and D. R. Adams. 2003. PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization. Biochem. J. 370:1.
24. Conti, M., W. Richter, C. Mehats, G. Livera, J. Y. Park, and C. Jin. 2003. Cyclic AMP-specific PDE4 phosphodiesterases as critical components of cyclic AMP signaling. J. Biol. Chem. 278:5493.
25. Bloom, T. J., and J. A. Beavo. 1996. Identification and tissue-specific expression of PDE7 phosphodiesterase splice variants. Proc. Natl. Acad. Sci. USA 93:14188.
26. Beavo, J. A., P. J. Bechtel, and E. G. Krebs. 1974. Preparation of homogeneous cyclic AMP-dependent protein kinase(s) and its subunits from rabbit skeletal muscle. Methods Enzymol. 38:299.
27. Schillace, R. V., J. W. Voltz, A. T. Sim, S. Shenolikar, and J. D. Scott. 2001. Multiple interactions within the AKAP220 signaling complex contribute to protein phosphatase 1 regulation. J. Biol. Chem. 276:12128.
28. Williams, R. O. 2002. Cutting edge: A-kinase anchor proteins are involved in maintaining resting T cells in an inactive state. J. Immunol. 168:5392.
29. Furusawa, M., T. Taira, S. M. Iguchi-Ariga, and H. Ariga. 2002. AMY-1 interacts with S-AKAP84 and AKAP95 in the cytoplasm and the nucleus, respectively, and inhibits cAMP-dependent protein kinase activity by preventing binding of its catalytic subunit to A-kinase-anchoring protein (AKAP) complex. J. Biol. Chem. 277:50885.
30. 1 phase. J. Cell Sci. 116:2237.
31. Kapiloff, M. S., R. V. Schillace, A. M. Westphal, and J. D. Scott. 1999. mAKAP: an A-kinase anchoring protein targeted to the nuclear membrane of differentiated myocytes. J. Cell Sci. 112:2725.
32. Marx, S. O., S. Reiken, Y. Hisamatsu, T. Jayaraman, D. Burkhoff, N. Rosemblit, and A. R. Marks. 2000. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 101:365.
33. Robichaud, A., C. Savoie, P. B. Stamatiou, F. D. Tattersall, and C. C. Chan. 2001. PDE4 inhibitors induce emesis in ferrets via a noradrenergic pathway. Neuropharmacology 40:262.
34. Barnette, M. S. 1999. Phosphodiesterase 4 (PDE4) inhibitors in asthma and chronic obstructive pulmonary disease (COPD). Prog. Drug Res. 53:193.
35. Erdogan, S., and M. D. Houslay. 1997. Challenge of human Jurkat T-cells with the adenylate cyclase activator forskolin elicits major changes in cAMP phosphodiesterase (PDE) expression by up-regulating PDE3 and inducing PDE4D1 and PDE4D2 splice variants as well as down-regulating a novel PDE4A splice variant. Biochem. J. 321:165.
36. Verghese, M. W., R. T. McConnell, J. M. Lenhard, L. Hamacher, and S. L. Jin. 1995. Regulation of distinct cyclic AMP-specific phosphodiesterase (phosphodiesterase type 4) isozymes in human monocytic cells. Mol. Pharmacol. 47:1164.
37. Smith, S. J., S. Brookes-Fazakerley, L. E. Donnelly, P. J. Barnes, M. S. Barnette, and M. A. Giembycz. 2003. Ubiquitous expression of phosphodiesterase 7A in human proinflammatory and immune cells. Am. J. Physiol. Lung Cell Mol. Physiol. 284:L279.